Categories: Insider Trading News

Recursion Prescribed drugs CEO sells shares value $287,200

Recent Posts

Huntington Bancshares’ SWOT evaluation: inventory poised for progress amid challenges

Huntington Bancshares Included (NASDAQ:HBAN), a outstanding participant within the U.S. banking sector with a market…

46 seconds ago

Factbox-Brokerages reduce predictions for 2025 Fed cuts after payrolls knowledge

Factbox-Brokerages reduce predictions for 2025 Fed cuts after payrolls knowledge

6 minutes ago

Greenback steadies, yen positive factors forward of BOJ assembly

By Tom Westbrook SINGAPORE (Reuters) -The greenback steadied on Thursday, after dipping alongside cooling U.S.…

16 minutes ago

TSMC logs file quarterly revenue, sees hefty income progress in early 2025

By Yimou Lee, Ben Blanchard and Religion Hung TAIPEI (Reuters) -Taiwan Semiconductor Manufacturing Co logged…

21 minutes ago

UK financial system grows by lower-than-expected 0.1% in November

LONDON (Reuters) -Britain's financial output rose for the primary time in three months in November…

21 minutes ago

Fathom Holdings chief dealer officer sells $1,260 in inventory

Samantha Giuggio, Chief Dealer Officer at Fathom Holdings Inc. (NASDAQ:FTHM), not too long ago reported…

31 minutes ago